EGFR/MDM2 signaling promotes NF-κB activation via PPARγ degradation.
Xu Y, Jin J, Zhang W, Zhang Z, Gao J, Liu Q, Zhou C, Xu Q, Shi H, Hou Y, Shi J.
Xu Y, et al. Among authors: zhang w, zhang z.
Carcinogenesis. 2016 Feb;37(2):215-222. doi: 10.1093/carcin/bgv252. Epub 2015 Dec 30.
Carcinogenesis. 2016.
PMID: 26718225